🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies the effectiveness of lapatinib ditosylate (lapa...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01557764
Treatments Being Tested
The purpose of this epidemiologic study is to establish a population-based ...
Status
Completed
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT01077648
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2007-10-10
Trial ID
NCT00543504
Treatments Being Tested
A retrospective cohort study using the LabRx medical claims database will b...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT01098500
Treatments Being Tested
It will be conducted as an international multicenter prospective observatio...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-02
Trial ID
NCT01160094
Treatments Being Tested
This is a phase I/II study to determine the safety and gain insight into th...
Status
Completed
Location
Duke University Medical Center
Start Date
2009-07
Trial ID
NCT00952692
Treatments Being Tested
This randomized phase I/II trial studies the side effects and best dose of ...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2009-08-19
Trial ID
NCT00555152
Treatments Being Tested
The objective of the trial was to evaluate the efficacy of the association ...
Status
Terminated
Location
Centre François Baclesse
Start Date
2008-03
Trial ID
NCT00888810
RATIONALE: GW572016 may stop the growth of tumor cells by blocking the enzy...
Status
Completed
Location
Jonsson Comprehensive Cancer Center, UCLA
Start Date
2004-03
Trial ID
NCT00085020
Treatments Being Tested